Morphine Sulfate
Product Images NDC 0228-4311

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Morphine Sulfate (NDC 0228-4311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of morphine sulfate depicted in the image, illustrating its molecular configuration. The diagram shows the arrangement of atoms and bonds characteristic of morphine sulfate as used in pharmaceutical products by Actavis Pharma, Inc.*

FDA Label Image

Image 10

Chemical structure diagram of morphine sulfate showing its molecular framework with labeled atoms and bonds representing the compound's chemical composition.*

FDA Label Image

Image 11

Chemical structure diagram of Morphine sulfate, showing the molecular framework of the active ingredient from the Morphine sulfate product by Actavis Pharma, Inc.*

FDA Label Image

Image 12

Morphine Sulfate Extended-Release Tablets 15 mg label from Actavis Pharma, Inc. The label includes instructions to swallow tablets whole and warnings against breaking, crushing, dissolving, or chewing. It states each tablet contains 15 mg of Morphine Sulfate, USP, and advises dispensing the accompanying Medication Guide. Storage instructions and manufacturer details for Teva Pharmaceuticals, Parsippany, NJ, are provided.*

FDA Label Image

Image 13

Morphine Sulfate Extended-Release Tablets 30 mg label from Actavis Pharma, Inc. The label indicates 100 tablets per container and specifies that tablets should be swallowed whole without breaking, crushing, dissolving, or chewing. It includes handling and storage instructions, medication guide dispensing instructions, and the manufacturer's information.*

FDA Label Image

Image 14

Label for Morphine Sulfate Extended-Release Tablets 60 mg by Actavis Pharma, Inc., showing NDC 0228-4311-11. The label instructs swallowing tablets whole and mentions a pharmacist directive to dispense the Medication Guide. The package contains 100 tablets and includes storage instructions and manufacturer information for Teva Pharmaceuticals, Parsippany, NJ.*

FDA Label Image

Image 15

Label for Morphine Sulfate Extended-Release Tablets 100 mg from Actavis Pharma, Inc. The label includes dosing instructions, pharmacist guidance, storage conditions, and a serialization coding area. The package contains 100 tablets intended for opioid-tolerant patients, with specific warnings against breaking, crushing, dissolving, or chewing the tablets.*

FDA Label Image

Image 16

Morphine Sulfate Extended-Release Tablets 200 mg label from Actavis Pharma, Inc. The label includes directions to swallow tablets whole and store at controlled room temperature. It indicates the product is for opioid-tolerant patients only, prescription use, and contains 100 tablets. The label also features the NDC 0228-4347-11 and Teva Pharmaceuticals details.*

FDA Label Image

Image 2

Chemical structure diagram of morphine sulfate showing atom connectivity and molecular configuration, labeled with morphine sulfate name.*

FDA Label Image

Image 3

Chemical structure of Morphine sulfate, showing its molecular arrangement with multiple rings and functional groups typical for this opioid compound.*

FDA Label Image

Image 4

Chemical structure of Morphine sulfate as depicted in the image, showing the molecular arrangement typical of this opioid analgesic compound.*

FDA Label Image

Image 5

Morphine sulfate blister packaging shows 10 tablets arranged in two rows of five. Each tablet is round, white, and scored. The label includes the proprietary name Morphine sulfate and the labeler Actavis Pharma, Inc., with visible regulatory and lot number markings on the packaging foil.*

FDA Label Image

Image 6

Chemical structure of morphine sulfate dihydrate depicted as two morphine molecules complexed with sulfuric acid and water molecules. The diagram includes distinct functional groups and stereochemistry relevant to morphine sulfate.*

FDA Label Image

Image 7

Chemical structure of morphine sulfate showing the molecular arrangement of its atoms and bonds as commonly represented in pharmaceutical labeling.*

FDA Label Image

Image 8

Chemical structure diagram of morphine sulfate showing its molecular bonds and atomic arrangement. The structure illustrates the characteristic morphine framework central to the active ingredient in the drug product labeled Morphine sulfate by Actavis Pharma, Inc.*

FDA Label Image

Image 9

Chemical structure of morphine sulfate, showing the molecular arrangement and bonds of morphine sulfate as depicted in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.